Correlation Between Covalon Technologies and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Covalon Technologies and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Covalon Technologies and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Covalon Technologies and Processa Pharmaceuticals, you can compare the effects of market volatilities on Covalon Technologies and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Covalon Technologies with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Covalon Technologies and Processa Pharmaceuticals.

Diversification Opportunities for Covalon Technologies and Processa Pharmaceuticals

-0.79

Correlation Coefficient

Covalon Technologies  Processa Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Covalon and Processa is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Covalon Technologies and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Covalon Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Covalon Technologies are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Covalon Technologies i.e., Covalon Technologies and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Covalon Technologies and Processa Pharmaceuticals

Assuming the 90 days horizon Covalon Technologies is expected to generate 0.52 times more return on investment than Processa Pharmaceuticals. However, Covalon Technologies is 1.94 times less risky than Processa Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  220.00  in Covalon Technologies on September 12, 2024 and sell it today you would earn a total of  34.00  from holding Covalon Technologies or generate 15.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Covalon Technologies  vs.  Processa Pharmaceuticals

Covalon Technologies

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Covalon Technologies are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Covalon Technologies reported solid returns over the last few months and may actually be approaching a breakup point.

Processa Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Processa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Covalon Technologies and Processa Pharmaceuticals

The main advantage of trading using opposite Covalon Technologies and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Covalon Technologies position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Covalon Technologies and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.